COVID-19–associated multisystem inflammatory syndrome in children
COVID-19–associated multisystem inflammatory syndrome in children
Definition
A inflammatory syndrome in children infected by the SARS-CoV-2 with similarities to Kawasaki disease. Clinical manifestations range from fever and inflammation to myocardial injury, shock, and development of coronary artery aneurysms.
Also known as COVID-19 -related paediatric inflammatory multisystem syndrome, COVID-19 -related pediatric inflammatory multisystem syndrome, COVID-19 associated multisystem inflammatory syndrome in children, COVID-19 Kawasaki-like syndrome, MIS-C, multisystem inflammatory syndrome in children, multisystem inflammatory syndrome in children associated with coronavirus disease 2019, multisystem inflammatory syndrome in children associated with COVID-19, paediatric inflammatory multisystem syndrome, paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2, paediatric inflammatory multisystem syndrome: temporally associated with SARS-CoV-2, paediatric multi-system inflammatory syndrome potentially associated with COVID-19, paediatric multisystem inflammatory syndrome, pediatric inflammatory multisystem syndrome, pediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2, pediatric inflammatory multisystem syndrome: temporally associated with SARS-CoV-2, pediatric multi-system inflammatory syndrome potentially associated with COVID-19, pediatric multisystem inflammatory syndrome, PIMS, PIMS-TS, PMIS, SARS-CoV-2 Kawasaki-like syndrome — per MONDO